Abstract: The present invention discloses a pharmaceutical composition comprising 1-{3-[9-methoxy-7-(2-methoxyphenyl)-2,3,4,5-tetrahydro-1,4-benzoxazepine-4-carbonyl]phenyl}imidazolidin-2-one ; N-tert-butyl-2-{N-[(furan-2-yl)methyl]-2-[5-(4-methylphenyl)-2H-1,2,3,4-tetrazol-2-yl]acetamido}-2-(4-hydroxyphenyl)acetamide ; 3-[2-(2-{[(6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(4hydroxyphenyl) methyl]amino}-4-oxo-4,5-dihydro-1,3-thiazol-5-yl)acetamido]benzoic acid; 2-oxo-2-(1H-pyrrol-2-yl)ethyl 2-[(4-fluorophenyl)methoxy]benzoate ; and 5-(3-{[(3-bromo-4-hydroxy-5 methoxyphenyl) methylidene]amino}-2 (butylimino)- 2,3-dihydro-1,3-thiazol-4-yl)-2-hydroxybenzamide.The components are small molecule antagonists that increase the intracellular nitric oxide level by inhibiting the interaction between Nitric oxide synthase interacting proteins and inducible Nitric oxide synthase.
Description:PLEASE SEE THE ATTACHMENT , Claims:PLEASE SEE THE ATTACHMENT
| # | Name | Date |
|---|---|---|
| 1 | 202432093349-STATEMENT OF UNDERTAKING (FORM 3) [28-11-2024(online)].pdf | 2024-11-28 |
| 3 | 202432093349-Sequence Listing in txt [28-11-2024(online)].txt | 2024-11-28 |
| 4 | 202432093349-Sequence Listing in PDF [28-11-2024(online)].pdf | 2024-11-28 |
| 5 | 202432093349-REQUEST FOR EXAMINATION (FORM-18) [28-11-2024(online)].pdf | 2024-11-28 |
| 6 | 202432093349-PROOF OF RIGHT [28-11-2024(online)].pdf | 2024-11-28 |
| 7 | 202432093349-FORM FOR SMALL ENTITY(FORM-28) [28-11-2024(online)].pdf | 2024-11-28 |
| 8 | 202432093349-FORM 18 [28-11-2024(online)].pdf | 2024-11-28 |
| 9 | 202432093349-FORM 1 [28-11-2024(online)].pdf | 2024-11-28 |
| 10 | 202432093349-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [28-11-2024(online)].pdf | 2024-11-28 |
| 11 | 202432093349-EVIDENCE FOR REGISTRATION UNDER SSI [28-11-2024(online)].pdf | 2024-11-28 |
| 12 | 202432093349-EDUCATIONAL INSTITUTION(S) [28-11-2024(online)].pdf | 2024-11-28 |
| 13 | 202432093349-DRAWINGS [28-11-2024(online)].pdf | 2024-11-28 |
| 14 | 202432093349-DECLARATION OF INVENTORSHIP (FORM 5) [28-11-2024(online)].pdf | 2024-11-28 |
| 15 | 202432093349-COMPLETE SPECIFICATION [28-11-2024(online)].pdf | 2024-11-28 |
| 16 | 202432093349-FORM-26 [21-02-2025(online)].pdf | 2025-02-21 |
| 17 | 202432093349-FORM 3 [27-05-2025(online)].pdf | 2025-05-27 |